The CDK4/6 inhibitor LY2835219 has potent activity in combination with mTOR inhibitor in head and neck squamous cell carcinoma

Oncotarget
Bo Mi KuMyung-Ju Ahn

Abstract

Deletion of CDKN2A (p16) or amplification of CCND1 (cyclin D1) occurs commonly in head and neck squamous cell carcinoma (HNSCC) and induces sustained cyclin-dependent kinase (CDK) 4/6 activation. Here, we report the antiproliferative activity of LY2835219, a selective CDK4/6 inhibitor through inhibition of CDK4/6-dependent Ser780 phosphorylation in retinoblastoma (RB) and induction of cell cycle arrest in HNSCC cells. In addition, we demonstrated the antitumor effects of HNSCC xenografts to LY2835219 in vivo. Given the limited effect in HNSCC as a single-agent treatment with LY2835219, a combinational strategy is required to enhance antitumor activity. At the molecular level, we found that LY2835219 inhibited activation of AKT and ERK, but not mTOR. The combination of LY2835219 with mTOR inhibitor was found to be more effective than either drug alone in vitro and in vivo. Taken together, our findings suggest that a combinational treatment with LY2835219 and mTOR inhibitor is a promising therapeutic approach for HNSCC.

References

Jul 4, 2006·Cancer Chemotherapy and Pharmacology·Jing LinHai-Min Chen
Sep 12, 2008·The New England Journal of Medicine·Robert I Haddad, Dong M Shin
Apr 2, 2010·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Marika Nestor
Jul 30, 2011·Science·Nicolas StranskyJennifer R Grandis
Jan 28, 2012·Current Treatment Options in Oncology·Shaun A NguyenTerry A Day
Apr 17, 2012·Cell·Mathieu Laplante, David M Sabatini
Apr 26, 2012·Molecular Cancer Therapeutics·Dharmalingam SubramaniamShrikant Anant
Feb 26, 2013·Cancer Research·Qingsong LiuNathanael S Gray
Apr 19, 2013·Frontiers in Oncology·Lakshmipathi VadlakondaReddanna Pallu
Apr 27, 2013·Cancer Discovery·Curtis R PickeringMitchell J Frederick
May 7, 2013·Oncogene·Y J Choi, L Anders
Oct 1, 2013·International Journal of Radiation Oncology, Biology, Physics·Matthew G FuryDavid G Pfister
Oct 10, 2013·Biochemical and Biophysical Research Communications·Qiang LiLin-gen Xu
Jan 7, 2014·Expert Opinion on Investigational Drugs·Mathew C CasimiroRichard G Pestell
Jan 18, 2014·International Journal of Cancer. Journal International Du Cancer·Annette M LimBenjamin Solomon
Apr 11, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G MountziosA Psyrri
May 2, 2014·Frontiers in Oncology·Camillo PortaAlessandra Mosca
May 6, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mark A Dickson
May 23, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sonya C TateDamien M Cronier
Jun 10, 2014·Clinical Biochemistry·Yaghoub SafdariMahnaz Sadeghi
Aug 8, 2014·Journal of the National Cancer Institute·Zhiyong WangJ Silvio Gutkind
Jan 1, 2015·Pharmacology & Therapeutics·Vipin YadavSheng-Bin Peng

❮ Previous
Next ❯

Citations

Nov 3, 2017·Laryngoscope Investigative Otolaryngology·Carter Van Waes, Omar Musbahi
Apr 26, 2017·Journal of Hematology & Oncology·Hanxiao XuKongming Wu
May 31, 2018·Future Medicinal Chemistry·Amy B HeptinstallIan R Hardcastle
Apr 16, 2019·Current Opinion in Oncology·Gabrielle van Caloen, Jean-Pascal Machiels
Jun 29, 2018·International Journal of Molecular Sciences·Camilla EvangelistiAlberto M Martelli
Mar 13, 2020·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Camelia Billard-SanduEric Deutsch
Jul 28, 2020·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·A DasD Cachia
Jul 22, 2017·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Federica GanciGiovanni Blandino
Aug 18, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Inan OlmezBenjamin Purow
Aug 10, 2019·Cancer Research·Laia Martínez-CarreresLluis Fajas
Aug 1, 2018·Trends in Cell Biology·Shom GoelJean J Zhao
Jul 9, 2021·Cancer Management and Research·Ye HuMan Li

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft
flow cytometry
xenografts

Software Mentioned

CompuSyn
GraphPad Prism
ImageJ

Related Concepts

Related Feeds

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.